Skip to main content
Premium Trial:

Request an Annual Quote

Nicholas Valeriani

Roka Bioscience has named Nicholas Valeriani to its board. He has been CEO of the Gary and Mary West Health Institute since 2012. He recently announced he plans to retire from that position in early September. Prior to West Health, Valeriani was at Johnson & Johnson for 34 years. 

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.